Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Listening to a genius...(TLT best move).
View:
Post by wildbird1 on May 25, 2023 4:34pm

Listening to a genius...(TLT best move).

Before criticizing R.Dumoulin-White or TLT management, think about the fact that it was DrMcFarland that contacted TLT, in order to ask for help to prove her theory that Light could cure cancer.
R.Dumoulin took the time to listen to that genius(DrMcfarland), and understood that her light activated compound was something very very big.

R.Dumoulin-White started with nothing and now we are on the verge of BTD and or AA approval.

And TLT did it with only 313 million shares outstanding, which is a puny little number of shares if you consider that TLT is aiming at multiple cancer treatments(NMIBC,GBM,NSCLC) etc...

We all know that the SP is at .23$ for now, big deal......

I don't understand the posters that constantly throw dirt on TLT management.

TLT management deserve our appreciation for the heavy work they did, with so little money available.
Comment by Alamir1111 on May 25, 2023 4:48pm
Hi sf can you dig up some facts about history of tlt cause I doubt birdie here is malnutriciond. Lack of ?etc
Comment by RoseHeaven on May 25, 2023 5:31pm
Who is this guy "Alamir1111" relentlessly jamming the entire message board. 
Comment by RoseHeaven on May 25, 2023 5:34pm
Getting tired with his non-stop posting.
Comment by Alamir1111 on May 25, 2023 5:37pm
Meet you in heaven bro .in a bed of roses
Comment by Alamir1111 on May 25, 2023 6:13pm
Did you guys ever violated a wasp nest. Try it is fun
Comment by riverrrow on May 25, 2023 6:26pm
Just click on the three dots under his "picture" then click on "ignore this user".  Problem solved.
Comment by Johnandrose22 on May 25, 2023 6:30pm
Done...Thanks
Comment by Alamir1111 on May 25, 2023 6:49pm
Did that rr and john are not aviable no more love technologie
Comment by DJDawg on May 25, 2023 5:29pm
In all fairness it is a very specific concern about what he has been doing all these years. If I were in his shoes, being paid to do something for TLT, I would be meeting with every company I could find to discuss collaborations and raise some funds. I think if I did that for 5 yrs with the clinical data they have to show, I would have found a licensing deal in Turkey :) at the very least. I ...more  
Comment by gebremeskel on May 25, 2023 6:42pm
When the story is finally told - if the story is finally told - I think it will be revealed that Roger Dumoulin-White did everything in his power to raise money and talked to everybody there was to talk to and so far has made little headway with big pharma. The resistance to a photodynamic solution to bladder cancer is too strong. Maybe BTD and AA will finally convince them there is money to be ...more  
Comment by DJDawg on May 25, 2023 6:45pm
I think this thread has been exhausted so I'm happy to wrap. I'm very hopeful to be wrong and slightly worried to be right. Love the science. Wish it were further along :)
Comment by N0taP00p on May 25, 2023 6:50pm
@DJD and gebremeskel: Thank you both for your clear elaboration of the problem and what may be going on behind the scenes. Sounds very plausible that the past is hindering the present perception and that's why there's no headway made with funding, at least the way we think funding should be ideally done. And yes, great job by TLT and RDW to get it this far. Let's hope we get some good ...more  
Comment by jmm1228 on May 25, 2023 5:57pm
Bullseye Wildbied! 
Comment by ScienceFirst on May 26, 2023 6:08am
Great post Wildbird1. Roger did take the time to listen, even when the molecule of Dr. McFarland was just a concept. And 13y later, Theralase is still the only one pushing PDT/PDC.  Nobody else ever come close to jump in, like we did. ____________   wildbird1 - (5/25/2023 4:34:16 PM) Listening to a genius...(TLT best move). Before criticizing R.Dumoulin-White or ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250